Site-specific antibody-drug conjugation through an engineered glycotransferase and a chemically reactive sugar
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Site-specific antibody-drug conjugation through an engineered glycotransferase and a chemically reactive sugar
Authors
Keywords
-
Journal
mAbs
Volume 6, Issue 5, Pages 1190-1200
Publisher
Informa UK Limited
Online
2014-07-15
DOI
10.4161/mabs.29889
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enzyme-Mediated Methodology for the Site-Specific Radiolabeling of Antibodies Based on Catalyst-Free Click Chemistry
- (2013) Brian M. Zeglis et al. BIOCONJUGATE CHEMISTRY
- Site-specific antibody drug conjugates for cancer therapy
- (2013) Siler Panowski et al. mAbs
- Methods for site-specific drug conjugation to antibodies
- (2013) Christopher R Behrens et al. mAbs
- 3Drefine: Consistent protein structure refinement by optimizing hydrogen bonding network and atomic-level energy minimization
- (2013) Debswapna Bhattacharya et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Proposed mechanism of off-target toxicity for antibody–drug conjugates driven by mannose receptor uptake
- (2012) Boris Gorovits et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Impact of linker and conjugation chemistry on antigen binding, Fc receptor binding and thermal stability of model antibody-drug conjugates
- (2012) Mauro Acchione et al. mAbs
- Atomic resolution model of the antibody Fc interaction with the complement C1q component
- (2012) Sebastian Schneider et al. MOLECULAR IMMUNOLOGY
- Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates
- (2012) Ben-Quan Shen et al. NATURE BIOTECHNOLOGY
- Synthesis of site-specific antibody-drug conjugates using unnatural amino acids
- (2012) J. Y. Axup et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Trastuzumab Emtansine (T-DM1): A Novel Agent for Targeting HER2+ Breast Cancer
- (2011) Howard A. Burris et al. Clinical Breast Cancer
- Unique carbohydrate-carbohydrate interactions are required for high affinity binding between Fc RIII and antibodies lacking core fucose
- (2011) C. Ferrara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Site-Specific and Stoichiometric Modification of Antibodies by Bacterial Transglutaminase
- (2010) Simone Jeger et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Engineered Thio-Trastuzumab-DM1 Conjugate with an Improved Therapeutic Index to Target Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
- (2010) J. R. Junutula et al. CLINICAL CANCER RESEARCH
- Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions
- (2010) Gregory L. Moore et al. mAbs
- Automated minimization of steric clashes in protein structures
- (2010) Srinivas Ramachandran et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Molecularly Defined Antibody Conjugation through a Selenocysteine Interface
- (2009) Thomas Hofer et al. BIOCHEMISTRY
- Site Specific Conjugation of Fluoroprobes to the Remodeled Fc N-Glycans of Monoclonal Antibodies Using Mutant Glycosyltransferases: Application for Cell Surface Antigen Detection
- (2009) Elizabeth Boeggeman et al. BIOCONJUGATE CHEMISTRY
- PIGS: automatic prediction of antibody structures
- (2008) P. Marcatili et al. BIOINFORMATICS
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- (2008) Jagath R Junutula et al. NATURE BIOTECHNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search